SCHEMBL14166705

SCHEMBL14166705

COC(=O)CCCCCCCC=CCC=CCC=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
LMNA P02545 3/20 0.56
CYP3A4 P08684 3/20 0.55
ALOX15 P16050 3/20 0.55
HSD17B10 Q99714 3/20 0.55
TDP1 Q9NUW8 3/20 0.55
TSHR P16473 2/20 0.55
EPHX2 P34913 1/20 0.55
OXER1 Q8TDS5 3/20 0.54
ALOX5 P09917 2/20 0.54
F7 P08709 5/20 0.49
F3 P13726 5/20 0.49
KDM4E B2RXH2 3/20 0.49
PPARG P37231 3/20 0.49
PPARD Q03181 3/20 0.49
PPARA Q07869 3/20 0.49
MAPT P10636 2/20 0.49
FFAR1 O14842 2/20 0.49
CYP19A1 P11511 2/20 0.49
HPGD P15428 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15634237 1.00 ALDH1A1 (0.56) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL14241681 1.00 ALDH1A1 (0.56) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL4444400 0.98 ALDH1A1 (0.58) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL4444402 0.98 ALDH1A1 (0.58) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL9003288 0.98 ALDH1A1 (0.58) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL9975540 0.93 NR1I2 (0.53) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL17709725 0.93 ALDH1A1 (0.63) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL17709726 0.93 ALDH1A1 (0.63) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL17709719 0.93 ALDH1A1 (0.63) ALDH1A1LMNACYP3A4ALOX15HSD17B10
SCHEMBL17709720 0.93 ALDH1A1 (0.63) ALDH1A1LMNACYP3A4ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2717864-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS Dietz, Ulrich (DE) 2014-04-16 EP disclosed
US-20140099354-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS Dietz, Ulrich (DE) 2014-04-10 US disclosed
WO-2012168342-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS DIETZ ULRICH (DE) 2012-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140099354-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS PHOSPHO1, PTDSS1, LIPG ALDH1A1 2921/4885LMNA 338/4885CYP3A4 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.